Inspire Medical Systems (NYSE:INSP) Price Target Raised to $78.00

by · The Markets Daily

Inspire Medical Systems (NYSE:INSP – Free Report) had its price target lifted by Truist Financial from $62.00 to $78.00 in a research report report published on Wednesday,Benzinga reports. The firm currently has a hold rating on the stock.

Several other research firms have also recently commented on INSP. Piper Sandler lifted their target price on Inspire Medical Systems from $55.00 to $60.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Evercore set a $54.00 target price on Inspire Medical Systems in a research report on Tuesday, August 4th. UBS Group began coverage on Inspire Medical Systems in a research note on Tuesday, July 28th. They set a “sell” rating and a $39.00 price target on the stock. Weiss Ratings upgraded Inspire Medical Systems from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, September 22nd. Finally, KeyCorp reiterated a “sector weight” rating on shares of Inspire Medical Systems in a report on Tuesday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, Inspire Medical Systems has a consensus rating of “Hold” and a consensus target price of $68.82.

Read Our Latest Report on INSP

Inspire Medical Systems Price Performance

INSP opened at $68.72 on Wednesday. Inspire Medical Systems has a one year low of $38.91 and a one year high of $147.03. The company’s 50 day simple moving average is $66.26 and its 200-day simple moving average is $54.80. The stock has a market capitalization of $1.99 billion, a P/E ratio of 30.89, a price-to-earnings-growth ratio of 5.30 and a beta of 0.73.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The business had revenue of $200.58 million during the quarter, compared to analyst estimates of $194.72 million. During the same quarter last year, the business posted $0.45 earnings per share. Inspire Medical Systems’s revenue for the quarter was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. As a group, analysts anticipate that Inspire Medical Systems will post 1.24 EPS for the current year.

Insider Buying and Selling at Inspire Medical Systems

In other news, insider Jason Kelly sold 963 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the transaction, the insider owned 18,985 shares of the company’s stock, valued at $1,130,556.75. This represents a 4.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Inspire Medical Systems

A number of institutional investors and hedge funds have recently added to or reduced their stakes in INSP. GAMMA Investing LLC lifted its stake in Inspire Medical Systems by 25.0% in the third quarter. GAMMA Investing LLC now owns 1,526 shares of the company’s stock valued at $106,000 after buying an additional 305 shares during the period. Valeo Financial Advisors LLC acquired a new position in shares of Inspire Medical Systems during the 3rd quarter worth about $229,000. Envestnet Portfolio Solutions Inc. acquired a new position in shares of Inspire Medical Systems during the 2nd quarter worth about $296,000. WINTON GROUP Ltd increased its stake in shares of Inspire Medical Systems by 790.8% in the 2nd quarter. WINTON GROUP Ltd now owns 37,412 shares of the company’s stock valued at $1,669,000 after acquiring an additional 33,212 shares during the last quarter. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of Inspire Medical Systems in the 2nd quarter valued at about $131,000. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Company Profile

(Get Free Report)

Inspire Medical Systems, Inc is a medical technology company focused on developing and commercializing treatments for obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is the Inspire therapy system, an implantable device designed for certain adults with moderate to severe OSA who are unable to use or obtain consistent benefits from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses an implantable pulse generator, a stimulation lead and a sensing lead.

Further Reading